Corynanthe yohimbi

Related Terms

11-hydroxy-yohimbine, alpha-yohimbine, aphrodien, Corynanthe johimbi, Corynanthe yohimbi, corynine, indole alkaloids, iohimbina (Brazilian Portuguese), johimbe (Danish, Dutch, English, Hungarian), johimbi, kiima-johimbepuu (Estonian), P. yohimbe (CCD-X), Pausinystalia johimbe, Pausinystalia yohimbe, quebrachine, Rubiaceae (family), yohimbehe, yohimbehe cortex, yohimbeherinde, yohimbene, yohimbime, yohimbine, yohimbine hydrochloride, P.johimbe (Schumann) Beille.

Background

The terms yohimbine, yohimbine hydrochloride, and yohimbe bark extract are related but different. Yohimbine is an active chemical (indole alkaloid) found in the bark of the Pausinystalia yohimbe tree. Yohimbine hydrochloride is a standardized form of yohimbine that is available as a prescription drug in the United States. Research has shown it to be effective in the treatment of male impotence. Yohimbine hydrochloride has also been used for the treatment of sexual side effects caused by some antidepressants (SSRIs), as a blood pressure boosting agent, for dry mouth, and for nervous system dysfunction.
In general, there is a lack of research on yohimbe bark extract, which generally contains low concentrations of yohimbine (6% indole alkaloids, of which only 10-15% is yohimbine). Therefore it is unknown if commercial preparations share the same effects of yohimbine hydrochloride.

Evidence Table

These uses have been tested in humans or animals. Safety and effectiveness have not always been proven. Some of these conditions are potentially serious, and should be evaluated by a qualified healthcare provider. GRADE *
These uses have been tested in humans or animals. Safety and effectiveness have not always been proven. Some of these conditions are potentially serious, and should be evaluated by a qualified healthcare provider. GRADE *


Research on the effects of yohimbine in anxiety has shown mixed results. Further research is needed to draw conclusions.

C


Research on the effects of yohimbine in anxiety has shown mixed results. Further research is needed to draw conclusions.

C


Historically, yohimbe has been used for body building and enhancing athletic performance. Due to stimulant effects, it has been thought that yohimbe may enhance exercise performance, increase fat loss, and increase muscle mass. Limited research showed a lack of effect of yohimbe on total body mass or body muscle mass, but a decrease in fat mass among athletes. Further study is needed before a conclusion can be made.

C


Historically, yohimbe has been used for body building and enhancing athletic performance. Due to stimulant effects, it has been thought that yohimbe may enhance exercise performance, increase fat loss, and increase muscle mass. Limited research showed a lack of effect of yohimbe on total body mass or body muscle mass, but a decrease in fat mass among athletes. Further study is needed before a conclusion can be made.

C


Early evidence suggests that yohimbine in combination with an antidepressant may improve symptoms of depression. Research of yohimbine alone showed a lack of benefit in major depressive disorder. More research is needed before a firm conclusion can be made.

 C


Early evidence suggests that yohimbine in combination with an antidepressant may improve symptoms of depression. Research of yohimbine alone showed a lack of benefit in major depressive disorder. More research is needed before a firm conclusion can be made.

 C


Limited evidence reports that yohimbine may increase saliva production and help with dry mouth. More research is needed before a strong conclusion can be made.

 C


Limited evidence reports that yohimbine may increase saliva production and help with dry mouth. More research is needed before a strong conclusion can be made.

 C


Yohimbine hydrochloride is a prescription drug that has supporting evidence in treating male impotence. Although yohimbine is present in yohimbe bark extract, levels are variable and often very low. Therefore, although yohimbe bark has been used traditionally to reduce male erectile dysfunction, sufficient scientific evidence is lacking to form a firm conclusion in this area. Further research is needed.

 C


Yohimbine hydrochloride is a prescription drug that has supporting evidence in treating male impotence. Although yohimbine is present in yohimbe bark extract, levels are variable and often very low. Therefore, although yohimbe bark has been used traditionally to reduce male erectile dysfunction, sufficient scientific evidence is lacking to form a firm conclusion in this area. Further research is needed.

 C


It is theorized that yohimbine may improve orthostatic hypotension (lowering of blood pressure when standing up) or other symptoms of autonomic nervous system dysfunction. However, yohimbe bark extract may not contain significant amounts of yohimbine, and therefore may lack these proposed effects. More research is needed before a strong recommendation can be made.

 C


It is theorized that yohimbine may improve orthostatic hypotension (lowering of blood pressure when standing up) or other symptoms of autonomic nervous system dysfunction. However, yohimbe bark extract may not contain significant amounts of yohimbine, and therefore may lack these proposed effects. More research is needed before a strong recommendation can be made.

 C


Limited evidence suggested yohimbine hydrochloride as a potential agent to improve orgasmic dysfunction. More well designed studies are needed before a conclusion can be made.

 C


Limited evidence suggested yohimbine hydrochloride as a potential agent to improve orgasmic dysfunction. More well designed studies are needed before a conclusion can be made.

 C


Evidence supporting yohimbine use for orthosthatic hypotension, or low blood pressure upon standing up, is mixed. Further study is needed.

C


Evidence supporting yohimbine use for orthosthatic hypotension, or low blood pressure upon standing up, is mixed. Further study is needed.

C


Yohimbine hydrochloride, a standardized form of yohimbine that is available as a prescription drug in the United States, has been suggested to treat sexual dysfunction due to SSRI antidepressants. However, research in this area is limited, and more study is needed before a recommendation can be made.

C


Yohimbine hydrochloride, a standardized form of yohimbine that is available as a prescription drug in the United States, has been suggested to treat sexual dysfunction due to SSRI antidepressants. However, research in this area is limited, and more study is needed before a recommendation can be made.

C
* Key to grades

A: Strong scientific evidence for this use
B: Good scientific evidence for this use
C: Unclear scientific evidence for this use
D: Fair scientific evidence for this use (it may not work)
F: Strong scientific evidence against this use (it likley does not work)
* Key to grades

A: Strong scientific evidence for this use
B: Good scientific evidence for this use
C: Unclear scientific evidence for this use
D: Fair scientific evidence for this use (it may not work)
F: Strong scientific evidence against this use (it likley does not work)

Tradition / Theory

The below uses are based on tradition, scientific theories, or limited research. They often have not been thoroughly tested in humans, and safety and effectiveness have not always been proven. Some of these conditions are potentially serious, and should be evaluated by a qualified healthcare provider. There may be other proposed uses that are not listed below.

Dosing

Adults (over 18 years old)
Doses are based on those most commonly used in available trials for pharmaceutical standardized yohimbine hydrochloride. Available clinical studies are lacking for administration of over-the-counter yohimbe.
A tea can be prepared by simmering 5-10 teaspoons of shaved yohimbe bark in 1 pint of water (with a further suggestion of adding 0.5-1.0 grams of vitamin C to the tea). Safety and efficacy data are lacking for this preparation.
For anxiety, 10-20 milligrams of yohimbine has been taken by mouth once or once weekly by mouth 30-60 minutes prior to undergoing virtual reality exposure, fear conditioning, or claustrophobia extinction therapy for up to four weeks.
For athletic performance, 20 milligrams of yohimbine has been taken by mouth twice daily for 21 days.
For depression, 5-30 milligrams yohimbine has been taken by mouth 3-4 times daily for ten days.
For erectile dysfunction, 5-100 milligrams of yohimbine has been taken by mouth daily in 1-4 divided doses for 2-8 weeks.
For orgasm improvement in men, 20 milligrams of yohimbine has been taken by mouth with gradual increases up to 50 milligrams.
For orthostatic hypotension, 5.4-12 milligrams of yohimbine has been taken by mouth daily for up to six months.
For sexual dysfunction due to antidepressant drugs, 15 to18 milligrams of yohimbine have been taken by mouth daily in divided doses two to four hours before sexual activity for at least three weeks.
For dry mouth, 6 milligrams of yohimbine has been taken by mouth three times daily for five days.

Safety

The U.S. Food and Drug Administration does not strictly regulate herbs and supplements. There is no guarantee of strength, purity or safety of products, and effects may vary. You should always read product labels. If you have a medical condition, or are taking other drugs, herbs, or supplements, you should speak with a qualified healthcare provider before starting a new therapy. Consult a healthcare provider immediately if you experience side effects.

Interactions

Interactions with Drugs
Multiple interactions have been suggested with yohimbine hydrochloride, which may also apply to yohimbe bark extract, which contains variable (albeit low) amounts of yohimbine alkaloid.
Yohimbe may increase the risk of bleeding when taken with drugs that increase the risk of bleeding. Some examples include aspirin, anticoagulants ("blood thinners") such as warfarin (Coumadin?) or heparin, anti-platelet drugs such as clopidogrel (Plavix?), and non-steroidal anti-inflammatory drugs such as ibuprofen (Motrin?, Advil?) or naproxen (Naprosyn?, Aleve?).
Yohimbe may increase effects of diabetic medications. Caution is advised when using medications that may also lower blood sugar. People taking drugs for diabetes by mouth or insulin should be monitored closely by a qualified healthcare professional, including a pharmacist. Medication adjustments may be necessary.
Yohimbe may alter blood pressure. Caution is advised in people taking drugs that lower blood pressure.
Yohimbe may interfere with the way the body processes certain drugs using the liver's "cytochrome P450" enzyme system. As a result, the levels of these drugs may be altered in the blood, and may cause altered effects or potentially serious adverse reactions. People using any medications should check the package insert, and speak with a qualified healthcare professional, including a pharmacist, about possible interactions.
Agents for the skin, agents for the eyes, agents for the lungs, agents for the muscles or bones, agents for the stomach or intestines, agents that affect the heart, agents that affect the nervous system, agents that affect urine flow, agents that increase blood pressure, alpha blockers, androgens, anti-anxiety agents, anticholinergics, antidepressant agents (monoamine oxidase inhibitors (MAOIs), selective serotonin reuptake inhibitor (SSRI), tricyclic (TCAs)), antihistamines, anti-obesity agents, atomexetine, benzodiazepines, desipramine, dopamine antagonists, drugs that may lower seizure threshold, erectile dysfunction agents, exercise performance enhancement agents, hormonal agents, hydrocortisone, mood stabilizers, morphine, norepinephrine transporter blockers, opiate antagonists, phenothiazines, phenytoin, physostigmine, primidone, psychiatric agents, and sympathomimetics.

Attribution

This information is based on a systematic review of scientific literature edited and peer-reviewed by contributors to the Natural Standard Research Collaboration (www.naturalstandard.com).

Bibliography

Cimolai N and Cimolai T. Yohimbine use for physical enhancement and its potential toxicity. J Diet.Suppl 2011;8(4):346-354.
Galecki P, Depko A, Wozniak A, et al. [Depressive disorder, treatment and sexual dysfunction--part II]. Pol.Merkur Lekarski. 2011;31(184):256-259.
Garcia de Miguel B, Nutt DJ, Hood SD, et al. Elucidation of neurobiology of anxiety disorders in children through pharmacological challenge tests and cortisol measurements: a systematic review. J Psychopharmacol. 2012;26(4):431-442.
Gregorini L, Marco J, and Heusch G. Peri-interventional coronary vasomotion. J Mol.Cell Cardiol. 2012;52(4):883-889.
Ho CC and Tan HM. Rise of herbal and traditional medicine in erectile dysfunction management. Curr Urol.Rep. 2011;12(6):470-478.
Hofmann SG, Smits JA, Asnaani A, et al. Gutner, Cognitive enhancers for anxiety disorders. Pharmacol Biochem.Behav. 2011;99(2):275-284.
Kaplan JS, Arnkoff DB, Glass CR, et al. Avoidant coping in panic disorder: a yohimbine biological challenge study. Anxiety.Stress.Coping. 2012;25(4):425-442.
Meyerbroeker K, Powers MB, van Stegeren A, et al. Does yohimbine hydrochloride facilitate fear extinction in virtual reality treatment of fear of flying? A randomized placebo-controlled trial. Psychother.Psychosom. 2012;81(1):29-37.
Okamoto LE, Shibao C, Gamboa A, et al. Synergistic effect of norepinephrine transporter blockade and alpha-2 antagonism on blood pressure in autonomic failure. Hypertension 2012;59(3):650-656.
Schwabe L, Tegenthoff M, Hoffken O, et al. Simultaneous glucocorticoid and noradrenergic activity disrupts the neural basis of goal-directed action in the human brain. J Neurosci. 7-25-2012;32(30):10146-10155.
Shibao C, Okamoto L, and Biaggioni I. Pharmacotherapy of autonomic failure. Pharmacol Ther 2012;134(3):279-286.
Soeter M and Kindt M. Stimulation of the noradrenergic system during memory formation impairs extinction learning but not the disruption of reconsolidation. Neuropsychopharmacology 2012;37(5):1204-1215.
Sommer M, Braumann M, Althoff T, et al. Psychological and neuroendocrine responses to social stress and to the administration of the alpha-2-receptor antagonist, yohimbine, in highly trained endurance athletes in comparison to untrained healthy controls. Pharmacopsychiatry 2011;44(4):129-134.
Umhau JC, Schwandt ML, Usala J, et al. Pharmacologically induced alcohol craving in treatment seeking alcoholics correlates with alcoholism severity, but is insensitive to acamprosate. Neuropsychopharmacology 2011;36(6):1178-1186.
VandenBrink BM, Foti RS, Rock DA, et al. Prediction of CYP2D6 drug interactions from in vitro data: evidence for substrate-dependent inhibition. Drug Metab Dispos. 2012;40(1):47-53.